Efficacy of Naltrexone Treatment as Augmentation to SSRI in OCD Patients

N/ACompletedNCT00234689

Sheba Medical Center

Overview

Assessing the efficacy of Naltrexone as augmentation to SSRI in patients with OCD

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Masking

DOUBLE

Conditions

Obsessive Compulsive Disorder

Interventions

NaltrexoneDRUG

Eligibility

Sex: ALLMin age: 18 YearsMax age: 65 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Diagnosis of OCD * Treatment with SSRI for at least 10 weeks with no response Exclusion Criteria: * Suffering from any medical condition * treatment with opiates * chronic use of drugs * Hepatitis or other liver related diseases * Incapability to sign an informed consent

Locations (1)

Chaim Sheba Medical Center

Ramat Gan, Israel

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.